Bhavin Mukund Mehta's most recent trade in Kilitch Drugs(I) Ltd. was a Disposal of 841,046 Equity Shares done . Disclosure was reported to the exchange on Aug. 28, 2024 under the SEBI (Prohibition of Insider Trading) Regulations, 2015.
Bhavin Mukund Mehta's has made SAST transactions in Kilitch Drugs(I) Ltd. recently where a Acquisition of 1,111,768 shares done . Disclosure was reported to the exchange on April 22, 2022.
| Stock | Client Name | Client Category | Action* | Reported To/By Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Period | Regulation (Insider/SAST) | Security Type | Mode |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Kilitch DrugsI | Bhavin Mukund Mehta | Promoter & Director | Disposal | 28 Aug 2024 | 841,046 | 2,523,138 (15.69%) | 5.23% | 0 | 0 | 23 Aug 2024 23 Aug 2024 |
Insider Trading | Equity Shares | Inter-se Transfer |
| Kilitch DrugsI | Bhavin Mukund Mehta | Director | Acquisition | 25 Apr 2022 | 1,111,768 | 3,114,184 (19.96%) | 7.13% | 0 | 0 | 22 Apr 2022 22 Apr 2022 |
Insider Trading | Equity Shares | Inter-se Transfer |
| Kilitch DrugsI | Bhavin Mukund Mehta | Promoter | Acquisition | 25 Apr 2022 | 1,111,768 | 3,114,184 (19.98%) | 7.13% | - | 22 Apr 2022 22 Apr 2022 |
SAST (29(1)) | - | Inter-se Transfer |